Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer

Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group-based psilocybin-assisted intervention for treatment of depression in patients diagnosed with cancer.